Navigation Links
Vion Pharmaceuticals to Implement a One-for-Ten Reverse Stock Split
Date:2/20/2008

NEW HAVEN, Conn., Feb. 20 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION) today announced that the Company would implement a one-for-ten reverse split of its common stock, effective at 5:00 p.m. Eastern Time on Wednesday, February 20, 2008.

On a pre-split basis, Vion Pharmaceuticals has 81,017,569 shares outstanding as of February 19, 2008. As a result of the reverse stock split, every 10 shares of Vion Common Stock will be combined into one share of Vion Pharmaceuticals' Common Stock, reducing the total number of outstanding shares to approximately 8.1 million shares.

Shares held electronically through a brokerage will be automatically adjusted for the reverse split. Shareholders of record will receive a letter of transmittal from the Company's stock transfer agent, American Stock Transfer & Trust Company, with instructions about how to exchange their shares. Vion will pay cash in lieu of issuing fractional shares.

When the reverse split becomes effective, Vion Pharmaceuticals' 7.75% Convertible Senior Notes due 2012 (the "Notes") will have a conversion rate of 52.0833 shares of common stock per $1,000 Note. Holders of Vion Pharmaceuticals' warrants will receive a notice detailing post-split warrant shares and exercise prices.

Beginning on February 21, 2008, a "D" will be added to the Vion trading symbol for 20 trading days to designate that shares are trading on a post- split basis. After such time, the symbol will revert to "VION".

Alan Kessman, Chief Executive Officer, said, "This adjustment to our capital structure is important to implement in order to attempt to restore compliance with NASDAQ listing requirements, which we believe is in the best interest of our shareholders." He
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
2. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, February 27, 2008
3. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
4. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
5. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
6. Boehringer Ingelheim Pharmaceuticals, Inc. Receives the NCQA Seal Of Approval
7. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
8. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
9. Keryx Biopharmaceuticals Announces Additions to Management Team
10. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
11. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... 11, 2014 Central Florida board-certified veterinary ... partnerships with several Brevard County animal hospitals to bring ... been working in the area since January 2006, credentialed ... 2008, and is happy to now offer his expertise ... Christiansen has used stem cell therapy with Vet-Stem, Inc. ...
(Date:9/11/2014)... The Remedy Group , a retained ... organizations, has announced that Terry Souwannamuang has joined the ... in biopharma and managed care Terry steadily rose in ... brand new specialty pharmacy for a Portland-based managed care ... Terry has a Bachelor’s Degree in General Science with ...
(Date:9/10/2014)... BASEL , Schweiz, September 11, 2014 ... Register für Eierstockkrebs, die bei der Jahresversammlung ... vorgestellt wurden, bekräftigen die komplette Tumorprofilierung als ... Bericht von Caris Registry™ zeigte ein deutlich ... mit Eierstock-, Eileiter- oder primär peritonealem Krebs, ...
(Date:9/10/2014)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ), a ... host a conference call and webcast tomorrow, September 11, ... time). The live call may be accessed ... participant code 38075452. The webcast can be accessed live ... site at www.orexigen.com and will be archived ...
Breaking Biology Technology:Dr. Jeff Christiansen is Now Offering Stem Cell Therapy for Pets at Five Brevard County Animal Hospitals and Beyond 2Dr. Jeff Christiansen is Now Offering Stem Cell Therapy for Pets at Five Brevard County Animal Hospitals and Beyond 3The Remedy Group Announces Hiring of Managed Care and Specialty Pharmacy Veteran 2Verbesserte Überlebensrate von Patientinnen mit Eierstockkrebs, die Behandlungen nach Anleitung durch komplette Tumorprofilierung erhalten 2Verbesserte Überlebensrate von Patientinnen mit Eierstockkrebs, die Behandlungen nach Anleitung durch komplette Tumorprofilierung erhalten 3Verbesserte Überlebensrate von Patientinnen mit Eierstockkrebs, die Behandlungen nach Anleitung durch komplette Tumorprofilierung erhalten 4Verbesserte Überlebensrate von Patientinnen mit Eierstockkrebs, die Behandlungen nach Anleitung durch komplette Tumorprofilierung erhalten 5
... biomass and enzymes to produce hydrogen fuel, ethanol, and ... AgVest in Lake Delton last Thursday. , ,These ... the conference by the AgVest group, which focuses on ... specific recommendations, AgVest tries to hook up up-and-coming agricultural ...
... a PeopleSoft database for tracking alumni in favor ... used for 12 years. , ,Schools and colleges can access ... based on a database from 4D, Inc. , ... separate from the university. When the central database failed to ...
... has been less than overwhelming to Governor Jim Doyles ... private money in Wisconsins biotechnology future. Budget-conscious members of ... of stem-cell research have once again protested, and Milwaukee ... of Madison. , ,Doyle should address all legitimate gripes ...
Cached Biology Technology:Investors hear about new agricultural technology 2Alumni Association extends database help to university 2Alumni Association extends database help to university 3Wisconsin cannot afford to take a pass on Doyles biotech plan 2Wisconsin cannot afford to take a pass on Doyles biotech plan 3
(Date:9/11/2014)... treatise "Flora of Northumberland and Durham" by Nathaniel ... Books platform as an example of combining modern ... new sort of resource and data re-use. This publication ... the region, which can be seen as a model ... enriched re-publication marries the meticulous detail of old ...
(Date:9/11/2014)... Northeastern University researchers and their international colleagues have ... role of neutral evolution in the biogeographic distribution ... Thursday in the journal Science . The ... a neutral agent-based model"was co-authored by Ferdi Hellweger, ... of civil and environmental engineering; his doctoral student ...
(Date:9/11/2014)... -- Today at the TEDMED conference, Tute Genomics announced ... genome sequencing results at the fingertips of the individual ... The $1000 was announced earlier this year by Illumina, ... point towards widespread adoption of genome sequencing in research ... million variants per human genome, data analysis has become ...
Breaking Biology News(10 mins):Re-publication of 'Flora of Northumberland and Durham' (1831): A dramatic account of change 2Re-publication of 'Flora of Northumberland and Durham' (1831): A dramatic account of change 3Microbes evolve faster than ocean can disperse them 2Tute Genomics Launches MyGene Portal for Genome-guided Medicine 2Tute Genomics Launches MyGene Portal for Genome-guided Medicine 3
... Jan. 26, 2011 TGen Drug Development (TD2) ... should help speed new drugs safely into human testing ... Scottsdale, Ariz., provides drug development firms with expertise in ... regulatory approval steps of getting new drugs to patients ...
... ribbon worm discovered in Kosterhavet National Park in 2007 ... Pseudomicrura afzelii , a form of nemertean or ... at the University of Gothenburg, Sweden, using DNA technology. ... from the traditional, highly labour-intensive way of describing a ...
... 25, 2011Give caffeine to cells engineered to produce viruses used ... 8-times more virus, according to a paper published in ... Ann Liebert, Inc. ( www.liebertpub.com ). The paper is available ... inexpensive strategy for increasing lentivirus production was developed by Brian ...
Cached Biology News:Arizona companies team up, providing quick development of cancer drugs 2Researchers register new species using DNA-based description 2
Collected from normal, healthy animals in carefully maintained standing herds of US orgin. Pricing: $45/unit for 1 - 10 units...
NORMAL DONOR DONKEY SERUM...
Whole blood is collected from canines (any breed, either sex), refrigerated within 6 hours, processed within 24 hours and frozen at -20C....
anti-dansyl, rabbit IgG fraction *1 mg/mL* Secondary Detection; Anti-Dye and Anti-Hapten Antibodies...
Biology Products: